The Cxbladder Hematuria Clinical Utility Study
common.study.values.description
“The Cxbladder Hematuria Clinical Utility Study”
To evaluate the clinical utility associated with the integration of Cxbladder into the evaluation of subjects presenting with hematuria for evaluation of urothelial carcinoma (UC) without compromising detection of UC.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
 common.study.methods.has-drugs-no
                                        common.study.methods.has-drugs-no
                                 common.study.methods.is-healthy-yes
                                        common.study.methods.is-healthy-yes
                                Diagnostic Test - Cxbladder
The Cxbladder Triage test result will be provided to physicians for all "low risk" subjects on the test arm. If a "low risk" subject has a Cxbladder Triage negative test result then the indication is to rule out the subject without further assessment. The decision to rule-out or further evaluate is solely that of the physician and subject. If the "low risk" subjects are not Cxbladder Triage negative then a Cxbladder Detect test result will also be provided. The indication is further evaluation a ...read more on ClinicalTrials.org
participant.views.study.view.additional
participant.views.study.view.scientific-title
Use of a Multiplexed Molecular Biomarker Test Cxbladder, in Real World Decision Making to Provide Clinical Utility Using a Randomized Design
common.study.values.clinical-trial-id
NCT03988309
participant.views.study.view.id
b2kwzd
 
    
    